This report describes an ocular mast cell tumor in a 13-year-old female sport horse. Clinical examination revealed a solitary firm mass located in the ocular mucosa, protruding from behind the left lower eyelid. The lesion was surgically removed and submitted to histopathology. Microscopically, the mass was composed of sheets of well-differentiated neoplastic round cells circumscribed by delicate connective tissue. Positive Giemsa and Toluidine Blue staining confirmed the presence of cytoplasmic granules. Neoplastic cells showed strong membranous and mild diffuse cytoplasmic immunoreactivity for c-KIT and a low KI-67 proliferative index. Based on these findings, a diagnosis of ocular mast cell tumor was made. Six months after surgical removal, no evidence of ocular lesion recurrence was detected.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735312 | PMC |
| http://dx.doi.org/10.1294/jes.28.149 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ocular and palpebral manifestations of mastocytosis: A prospective single-center study.
Ann Dermatol Venereol
November 2024
Departement of Dermatology, Hôpital Privé Francheville, Périgueux, France. Electronic address:
Background: Ocular discomfort has been described as a frequent symptom in patients with mastocytosis, a rare disease resulting from accumulation of mast cells in organs.
Objectives: This study aims to assess the frequency and describe the nature of ocular and palpebral abnormalities in mastocytosis patients.
Patients And Methods: We conducted a prospective, single-center study in adult mastocytosis patients, who were systematically examined by a dermatologist and an ophthalmologist with determination of tear cytokine levels.
Mouse Corneal Immune Cell Heterogeneity Revealed by Single-Cell RNA Sequencing.
Invest Ophthalmol Vis Sci
October 2024
Ocular Surface Center, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, United States.
Purpose: This study aimed to define the heterogeneity, spatial localization, and functional roles of immune cells in the mouse cornea using single-cell RNA sequencing (scRNA-seq) and immunofluorescent staining.
Methods: Enriched mouse corneal immune cells (C57BL/6 strain, age 16-20 weeks) underwent single-cell RNA sequencing library preparation, sequencing, and analysis with Seurat, Monocle 3, and CellChat packages in R. Pathway analysis used Qiagen Ingenuity Pathway Analysis software.
Signaling pathways and targeted therapy for rosacea.
Front Immunol
October 2024
Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
Article Synopsis
- - Rosacea is a common, chronic skin condition affecting 1% to 20% of the global population, marked by symptoms like facial redness, small bumps, and potential eye issues, caused by a blend of genetic, environmental, and immune factors.
- - Recent research highlights specific molecular mechanisms involved in rosacea, such as the roles of LL37, TLR2, and mTOR pathways, which help activate immune cells and produce inflammatory cytokines, ultimately driving inflammation and blood vessel growth.
- - Current treatments for rosacea aim at managing symptoms, but new understanding of its underlying biology is paving the way for more precise therapies, including drugs that target particular cytokines and signaling pathways like IL-17 and JAK.
Granzyme B Expression in Conjunctiva of Patients with Pterygium.
Int J Mol Sci
August 2024
Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC V5Z 3N9, Canada.
Pterygium is often associated with chronic ultraviolet (UV) radiation exposure and characterized by the overgrowth of conjunctiva and extracellular matrix (ECM) remodeling. Notably, several studies in the skin have demonstrated that chronic UV radiation can upregulate Granzyme B (GrB) expression and increase ECM degradation. The aim of this study was to compare GrB expression between pterygium and healthy controls and to further link this GrB expression to mast cells.
View Article and Find Full Text PDFMicrobes exist at and colonize mucosal surfaces striking a balance with the host immune system, so that these microbes can thrive on host tissues without causing pathology. Because of this, mucosal barrier-colonizing bacteria can be leveraged to act as long-term delivery vehicles for naturally derived therapeutics. Here, we use a mouse model of corneal wound healing to show that the eye-colonizing bacterium, Corynebacterium mastitidis (C.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!